Bio-Rad Laboratories, Inc. a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced the availability of Biogazelle’s qbasePLUS, qPCR data ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), today announced the global launch of its CFX Opus 96 and CFX Opus 384 Real-time PCR Systems along with BR.io, a cloud-based instrument connectivity, ...

The CFX Opus 96 and CFX Opus 384 Real-Time PCR Systems represent the next generation of the company’s CFX Real-Time PCR Systems that are used in research and genomic testing as well as in pathogen ...

Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, today announced the launch of the CFX Duet Real-Time PCR System to support researchers in ...

HERCULES, Calif. - Bio-Rad Laboratories, Inc. (NYSE:BIO and BIO.B), a life sciences company with a market capitalization of $6.8 billion and strong financial health according to InvestingPro data, ...

DUBLIN--(BUSINESS WIRE)--The "Real-time PCR (qPCR) andDigital PCR (dPCR) Market Analysis by Technology, by Product (Consumables & Reagents, Instruments, Software & Services), by Application and ...

We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Bio-Rad Laboratories, Inc. stands tenth on our list and is currently making waves for launching a new ...